2027 MR in Clinical Practice Abstract Submission Guidelines

For the 2027 Annual Meeting, we are accepting submissions highlighting magnetic resonance imaging (MRI) in clinical practice.

Submitted abstracts should demonstrate the clinical utility of MRI and its direct impact on patient management. We encourage authors to construct the abstract as a narrative of the patient’s clinical history including unique medical and social factors as appropriate. An analysis of a series of cases is also appropriate for this category. The abstract must include specifics of the utilization, technical specifications, and contribution of MRI in the management of the patient’s clinical presentation.

All submitted abstracts will undergo peer review. Accepted abstracts will be presented on site at the 2027 ISMRM & ISMRT Annual Meeting in Vancouver, BC, Canada. At least one author must attend in person to present the work.

Abstracts will be evaluated based on the added value of MR in impacting patient care, particularly where this resulted in unique diagnostic or management insights. Examples include:

• Use of a specific MRI contrast that contributed to a patient’s diagnosis.
• Use of innovative, emerging, and advanced MR (e.g. MR spectroscopy) or MRI techniques in diagnosis or for therapy monitoring (e.g., diagnosis facilitated by a new pulse sequence, contrast agent, processing method, or new hardware, such as low-field MRI in a setting where MRI is otherwise unavailable).
• Report about the added value of MRI compared to other imaging modalities (e.g., CT, ultrasound, PET).
• Detection of disease features not visible with other imaging techniques.
• MR identifies complications or treatment side effects not captured by other imaging tests.

Required Abstract Structure

Title

• Suggested format: “MRI in Clinical Practice: Diagnosis of …” OR “MRI in Clinical Practice: Management of …”

Clinical Presentation and Assessment

• Brief report of patient presentation, physical exam findings, and relevant laboratory tests. No identifiers may be included.
• Describe MR scans, including MRI, used to work-up the patient. Highlight aspects (e.g., magnet strength, coil setup, pulse sequence, key scan parameters, contrast agent) of the MR technology.

Diagnosis and Treatment

• Report the final diagnosis, how the imaging diagnosis was confirmed (e.g., biopsy, follow-up imaging, combination of imaging and lab tests), and how the patient was treated.

Significance

• Describe how MR was applied in a novel or unique way to address the clinical question and highlight its impact on patient diagnosis or management. Emphasize how MR changed diagnostic certainty, influenced clinical decision-making or management, and/or improved patient outcomes.

Key Points

List at least three (3) key points about the disease and MR imaging manifestation or treatment impact relevant for clinical practice.

Figures

Include up to five (5) images with figure legends. Use arrows or labels to highlight critical features.

References

Please appropriately cite relevant previous work including background and methodological information.

Impact

A 40-word Impact statement should state the impact of MR: how it changed diagnostic certainty, management, or patient outcome. The impact statement will be provided alongside the preview figure as a teaser in the meeting program.

Synopsis

A 100-word unstructured Synopsis should be provided to summarize the report.

Submission Requirements

• Abstracts must not exceed 750 words.
• Up to five (5) figures may be included.
• A preview figure (for program display) must also be submitted, but will not be included in peer review.

Additional Submission Items

• Optional institutional/consortium logo image
• Grant funding, code, data, and supporting links must be included in the Acknowledgements only and will not be shared with reviewers.